State Duma Speaker Vyacheslav Volodin announced on Tuesday that new draft legislation to arm the government with more “counter-sanctions” against the United States would not affect 90 of the 1,019 American pharmaceutical products currently imported from the U.S., as these 90 drugs are not manufactured domestically and aren’t available in other countries.
“Let’s try to calm the public,” Volodin said on the cable news television station Rossiya 24, explaining that lawmakers would meet with “the expert community and business groups affected by this law,” before voting on a second reading of the legislation.
